The effects and mechanisms of mycophenolate mofetil on pulmonary arterial hypertension in rats

Rheumatology International

Volumn 30, Issue 3, 2010, Pages 341-348

  Zheng, Yi ^a   Li, Mingwei ^a   Zhang, Yongfeng ^a   Shi, Xuhua ^a   Li, Luling ^a   Jin, Mulan ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Mycophenolate mofetil; Pulmonary arterial hypertension; Pulmonary artery; Rat; Smooth muscle cells

Indexed keywords

MONOCROTALINE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY MUSCLE; ARTERY WALL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; HEMODYNAMICS; MALE; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; RAT;

ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPERTENSION, PULMONARY; HYPERTROPHY; IMMUNOSUPPRESSIVE AGENTS; MALE; MONOCROTALINE; MUSCLE, SMOOTH, VASCULAR; MYCOPHENOLIC ACID; PULMONARY ARTERY; RATS; RATS, SPRAGUE-DAWLEY; TREATMENT OUTCOME;

EID: 73649120629     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-009-0966-8     Document Type: Article

References (19)

1. HW Farber J Loscalzo 2004 Pulmonary arterial hypertension N Engl J Med 351 1655 1665 10.1056/NEJMra035488 10.1056/NEJMra035488 1:CAS:528: DC%2BD2cXos1Whtbg%3D 15483284 (Pubitemid 39350426)
2. A Puri MD McGoon SS Kushwaha 2007 Pulmonary arterial hypertension: current therapeutic strategies Nat Clin Pract Cardiovasc Med 4 319 329 10.1038/ncpcardio0890 10.1038/ncpcardio0890 1:CAS:528:DC%2BD2sXlsFOhsLw%3D 17522721 (Pubitemid 46860549)
3. H Shimizu M Takahashi S Takeda, et al. 2004 Mycophenolate mofetil prevents transplant arteriosclerosis by direct inhibition of vascular smooth muscle cell proliferation Transplantation 77 1661 1667 10.1097/01.TP.0000127592. 13707.B6 10.1097/01.TP.0000127592.13707.B6 1:CAS:528:DC%2BD2cXkvVOjtbk%3D 15201664 (Pubitemid 38780531)
4. R Voisard L Gecquner R Baur, et al. 2005 Antiproliferative profile of sirolimus and mycophenolate mofetil: impact of the SI/MPL ratio Int J Cardiol 102 435 442 10.1016/j.ijcard.2004.05.039 10.1016/j.ijcard.2004.05.039 16004888 (Pubitemid 40956904)
5. DW Lipke SS Arcot MN Gillespie, et al. 1993 Temporal alterations in specific basement components in lungs from monocrotaline-treated rats Am J Respir Cell Mol Biol 9 418 428 1:CAS:528:DyaK2cXhvVCrt7c%3D 8398180
6. MH Hessel P Steendijk B den Adel, et al. 2006 Characterization of right ventricular function after monocrotaline-induced pulmonary hypertension in the intact rat Am J Physiol Heart Circ Physiol 291 H2424 H2430 10.1152/ajpheart. 00369.2006 10.1152/ajpheart.00369.2006 1:CAS:528:DC%2BD28Xht1Gnsb%2FJ 16731643 (Pubitemid 44776673)
7. T Mosmann 1983 Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J Immunol Methods 65 55 63 10.1016/0022-1759(83)90303-4 10.1016/0022-1759(83)90303-4 1:STN:280: DyaL2c%2FovFSmtw%3D%3D 6606682
8. JG Coghlan C Handler 2006 Connective tissue associated pulmonary arterial hypertension Lupus 15 138 142 10.1191/0961203306lu2280rr 10.1191/ 0961203306lu2280rr 1:STN:280:DC%2BD283is1Omug%3D%3D 16634366
9. M Mandegar YC Fung W Huang, et al. 2004 Cellular and molecular mechanisms of pulmonary vascular remodeling: role in the development of pulmonary hypertension Microvasc Res 68 75 103 10.1016/j.mvr.2004.06.001 10.1016/j.mvr.2004.06.001 1:CAS:528:DC%2BD2cXmslalsL4%3D 15313118 (Pubitemid 39093882)
10. G Simonneau N Galiè LJ Rubin, et al. 2004 Clinical classification of pulmonary hypertension J Am Coll Cardiol 43 5S 12S 10.1016/j.jacc.2004.02.037 10.1016/j.jacc.2004.02.037 15194173 (Pubitemid 38759712)
11. N Kasitanon M Petri M Haas, et al. 2008 Mycophenolate mofetil as the primary treatment of membranous lupus nephritis with and without concurrent proliferative disease: a retrospective study of 29 cases Lupus 17 40 45 10.1177/0961203307085114 10.1177/0961203307085114 1:CAS:528:DC%2BD1cXhtVymsr3O 18089682
12. J Kahu A Lõhmus M Ilmoja, et al. 2007 Successful rescue therapy with mycophenolate mofetil in kidney transplantation improves the long-term graft survival Medicina (Kaunas) 43 953 958
13. TS Mele PF Halloran 2000 The use of mycophenolate mofetil in transplant recipients Immunopharmacology 47 215 245 10.1016/S0162-3109(00)00190-9 10.1016/S0162-3109(00)00190-9 1:CAS:528:DC%2BD3cXktlKktL4%3D 10878291 (Pubitemid 30394540)
14. Y Huang Z Liu H Huang, et al. 2005 Effects of mycophenolic acid on endothelial cells Int Immunopharmacol 5 1029 1039 10.1016/j.intimp.2005.01.015 10.1016/j.intimp.2005.01.015 1:CAS:528:DC%2BD2MXjtF2ht74%3D 15829418
15. C Morath M Zeier 2003 Review of the antiproliferative properties of mycophenolate mofetil in non-immune cells Int J Clin Pharmacol Ther 41 465 469 1:CAS:528:DC%2BD3sXos1WnsLg%3D 14703952
16. C Suzuki M Takahashi H Morimoto, et al. 2006 Mycophenolate mofetil attenuates pulmonary arterial hypertension in rats Biochem Biophys Res Commun 349 781 788 10.1016/j.bbrc.2006.08.109 10.1016/j.bbrc.2006.08.109 1:CAS:528:DC%2BD28Xps1OgtrY%3D 16956581 (Pubitemid 44344582)
17. A Räisänen-Sokolowski P Vuoristo M Myllärniemi, et al. 1995 Mycophenolate mofetil (MMF, RS-61443) inhibits inflammation and smooth muscle cell proliferation in rat aortic allografts Transpl Immunol 3 342 351 10.1016/0966-3274(95)80021-2 10.1016/0966-3274(95)80021-2 8665154 (Pubitemid 26046368)
18. JI Moon YS Kim MS Kim, et al. 2000 Effect of cyclosporine, mycophenolic acid, and rapamycin on the proliferation of rat aortic vascular smooth muscle cells: in vitro study Transplant Proc 32 2026 2027 10.1016/S0041-1345(00)01542-6 10.1016/S0041-1345(00)01542-6 1:CAS:528:DC%2BD3cXovFKiuro%3D 11120050
19. I Dubus S Sena JP Labouyrie, et al. 2005 In vitro prevention of cyclosporin-induced cell contraction by mycophenolic acid Life Sci 77 3366 3374 10.1016/j.lfs.2005.05.050 10.1016/j.lfs.2005.05.050 1:CAS:528:DC%2BD2MXhtFShs7fE 15978635 (Pubitemid 41434079)